FDA Approved: ADREVIEW — Original Application (Medi-Physics Inc.)

View source ↗

Summary

FDA approved the original application for ADREVIEW (IOBENGUANE I-123) from Medi-Physics Inc., a radiopharmaceutical imaging agent for locating pheochromocytoma …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma
• Pheochromocytoma

Drugs mentioned

• ADREVIEW (IOBENGUANE I-123)

Snippet

ORIG AP for ADREVIEW (IOBENGUANE I-123)